171 related articles for article (PubMed ID: 31960419)
41. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis.
Parikh SA; Kapoor P; Letendre L; Kumar S; Wolanskyj AP
Mayo Clin Proc; 2014 Apr; 89(4):484-92. PubMed ID: 24581757
[TBL] [Abstract][Full Text] [Related]
42. The prevalence and prognosis of hyponatraemia in non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis.
Yin G; Man C; Cheng W; Gao X; Wang J; Tian T; Xu J; Duan L; Qiu H
Leuk Lymphoma; 2022 Feb; 63(2):362-369. PubMed ID: 34661498
[TBL] [Abstract][Full Text] [Related]
43. Dual Threat of Epstein-Barr Virus: an Autopsy Case Report of HIV-Positive Plasmablastic Lymphoma Complicating EBV-Associated Hemophagocytic Lymphohistiocytosis.
Koizumi Y; Imadome KI; Ota Y; Minamiguchi H; Kodama Y; Watanabe D; Mikamo H; Uehira T; Okada S; Shirasaka T
J Clin Immunol; 2018 May; 38(4):478-483. PubMed ID: 29687211
[TBL] [Abstract][Full Text] [Related]
44. Hemophagocytic lymphohistiocytosis as a harbinger of aggressive lymphoma: a case series.
Pasvolsky O; Zoref-Lorenz A; Abadi U; Geiger KR; Hayman L; Vaxman I; Raanani P; Leader A
Int J Hematol; 2019 May; 109(5):553-562. PubMed ID: 30850926
[TBL] [Abstract][Full Text] [Related]
45. Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T- and/or NK-cell lymphoma.
Liu Y; Sardana R; Nemirovsky D; Frosina D; Jungbluth A; Johnson WT; Vardhana S; Arcila M; Horwitz SM; Derkach A; Dogan A; Xiao W
Blood Adv; 2024 Jun; 8(12):3064-3075. PubMed ID: 38593227
[TBL] [Abstract][Full Text] [Related]
46. Natural Killer Cell Function Tests by Flowcytometry-Based Cytotoxicity and IFN-γ Production for the Diagnosis of Adult Hemophagocytic Lymphohistiocytosis.
Lee H; Kim HS; Lee JM; Park KH; Choi AR; Yoon JH; Ryu H; Oh EJ
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671661
[TBL] [Abstract][Full Text] [Related]
47. Modified DEP regimen as induction therapy for lymphoma-associated hemophagocytic lymphohistiocytosis: a prospective, multicenter study.
Pi Y; Wang J; Zhou H; Ye X; Sun X; Liu L; Pan X; Wang Z
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3033-3041. PubMed ID: 35852619
[TBL] [Abstract][Full Text] [Related]
48. Possible prediction of underlying lymphoma by high sIL-2R/ferritin ratio in hemophagocytic syndrome.
Tabata C; Tabata R
Ann Hematol; 2012 Jan; 91(1):63-71. PubMed ID: 21523380
[TBL] [Abstract][Full Text] [Related]
49. Malignancy-associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes.
Tamamyan GN; Kantarjian HM; Ning J; Jain P; Sasaki K; McClain KL; Allen CE; Pierce SA; Cortes JE; Ravandi F; Konopleva MY; Garcia-Manero G; Benton CB; Chihara D; Rytting ME; Wang S; Abdelall W; Konoplev SN; Daver NG
Cancer; 2016 Sep; 122(18):2857-66. PubMed ID: 27244347
[TBL] [Abstract][Full Text] [Related]
50. Patients with an extraordinarily elevated serum ferritin: think of haemophagocytic lymphohistiocytosis.
Schweizer M; Goede JS; Briner V
Swiss Med Wkly; 2015; 145():w14152. PubMed ID: 26098856
[TBL] [Abstract][Full Text] [Related]
51. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis.
Allen CE; Yu X; Kozinetz CA; McClain KL
Pediatr Blood Cancer; 2008 Jun; 50(6):1227-35. PubMed ID: 18085676
[TBL] [Abstract][Full Text] [Related]
52. Clinical characteristics, therapy response, and outcome of 51 adult patients with hematological malignancy-associated hemophagocytic lymphohistiocytosis: a single institution experience.
Lorenz F; Klimkowska M; Pawłowicz E; Bulanda Brustad A; Erlanson M; Machaczka M
Leuk Lymphoma; 2018 Aug; 59(8):1840-1850. PubMed ID: 29295642
[TBL] [Abstract][Full Text] [Related]
53. Lymphoma-associated hemophagocytic lymphohistiocytosis: experience in adults from a single institution.
Yu JT; Wang CY; Yang Y; Wang RC; Chang KH; Hwang WL; Teng CL
Ann Hematol; 2013 Nov; 92(11):1529-36. PubMed ID: 23700280
[TBL] [Abstract][Full Text] [Related]
54. [The clinical significance of plasma PTX3 in patients with secondary hemophagocytic lymphohistiocytosis].
Liu LL; Qiu HX; Xu J; Duan LM; Tian T; Wang JJ; Gao X; Yin GL; Huang JY; Cheng WY
Zhonghua Nei Ke Za Zhi; 2020 Jul; 59(7):528-534. PubMed ID: 32594686
[No Abstract] [Full Text] [Related]
55. Primary and secondary hemophagocytic lymphohistiocytosis have different patterns of T-cell activation, differentiation and repertoire.
Ammann S; Lehmberg K; Zur Stadt U; Janka G; Rensing-Ehl A; Klemann C; Heeg M; Bode S; Fuchs I; Ehl S;
Eur J Immunol; 2017 Feb; 47(2):364-373. PubMed ID: 27925643
[TBL] [Abstract][Full Text] [Related]
56. [Significance of soluble interleukin-2 receptor and NK cell activity in patients with hemophagocytic lymphohistiocytosis].
Wang LL; Hu YX; Chen WF; Xu J; Zhang W; Wu YJ; Tian T; Qiu HX; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):401-4. PubMed ID: 22541108
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic accuracy of a specific cytokine pattern in hemophagocytic lymphohistiocytosis in children.
Xu XJ; Tang YM; Song H; Yang SL; Xu WQ; Zhao N; Shi SW; Shen HP; Mao JQ; Zhang LY; Pan BH
J Pediatr; 2012 Jun; 160(6):984-90.e1. PubMed ID: 22226576
[TBL] [Abstract][Full Text] [Related]
58. [Clinical prognostic analysis of 124 adult patients with hemophagocytic lymphohistiocytosis: a multicenter retrospective study of the Huaihai Lymphoma Working Group].
Shen ZY; He CL; Sun Q; Zhang S; Hu LL; Liu QH; Zhang H; Liu X; Miao YQ; Gu WY; Wang F; Wang CL; Shi YY; Wang L; Jiao J; Ye JJ; Xu LY; Yan DM; Li ZY; Jin YL; Huang SP; Xu KL; Sang W
Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):800-806. PubMed ID: 34788918
[No Abstract] [Full Text] [Related]
59. Clinical significance of bone marrow hemophagocytosis in adult patients with malignancy and non-malignancy-induced hemophagocytic lymphohistiocytosis.
Lim SH; Park S; Jang JH; Kim K; Kim HJ; Kim SH; Kang CI; Chung DR; Peck KR; Lee J; Cha HS; Koh EM; Ko YH; Kim WS; Jung CW; Kim SJ
Ann Hematol; 2016 Jan; 95(2):325-35. PubMed ID: 26453074
[TBL] [Abstract][Full Text] [Related]
60. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
